Trial intelligence / Profile preview

Gilteritinib maintenance after allogeneic transplant for FLT3-ITD AML

2016-001061-83Phase 3Suspended

Sponsor

Astellas Pharma

Start

Jan 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1